Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70.04% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
English
Regional settings
Entity•Capital Com UK LimitedAuthorised and regulated by the Financial Conduct Authority (FCA)
Why Capital.com?
About us
Our history
Our offices
Leadership team
Client funds
How Capital.com makes money
Contact us
Terms and policies
Ways to trade
CFD trading
Spread betting
1X
Charges and fees
Professional
Margin Calls
Markets
Shares
Forex
Indices
Commodities
Trading platforms 
Web platform
Mobile apps
MT4
TradingView
Demo
Learn to trade
Essentials of trading
Risk-management guide
Market guides
Trading Strategies
Trading Psychology
Technical analysis
Market analysis
Help
My account

HomeMarketsSharesIpsen

Trade Ipsen - IPN CFD

SummaryHistorical Data
Trading Conditions
Spread0.48
Long position overnight fee
Long position overnight fee
Margin. Your investment
€1,000.00
Overnight fee
Charges from full value of position
-0.022091 %
(-€0.88)

Trade size with leverage ~ €5,000.00

Short position overnight fee ~ €4,000.00

-0.022091%
Short position overnight fee
Short position overnight fee
Margin. Your investment
€1,000.00
Overnight fee
Charges from full value of position
-0.000132 %
(-€0.01)

Trade size with leverage ~ €5,000.00

Short position overnight fee ~ €4,000.00

-0.000132%
Overnight fee time21:00 (UTC)
CurrencyEUR
Min traded quantity1
Margin20
Stock exchangeFrance
Commission on trade10%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close111.96
Open112.36
1-Year Change2.18%
Day's Range111.26 - 114.56

Ipsen Company profile

Founded in 1929, Ipsen (IPN) is a leading international biopharmaceutical group, focusing on specialty care. The company develops and produces innovative medicines in 3 major areas: rare diseases, neurosciences and oncology. Ipsen also runs a consumer healthcare business. In general, the company sells over 20 drugs in more than 115 countries worldwide. Ipsen's R&D is focused on its differentiated and innovative technological platforms in the leading biotechnological hubs, based in Cambridge, the US, Oxford, the UK, and Paris-Saclay, France. Headquartered in Paris, the company employs 5,100 specialists. Included to the CAC Mid 60 index, the Ipsen share price (IPN) is set and traded on the Euronext Paris exchange.